MEOH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Methanex is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 and an impatient mindset. The stock has supportive analyst revisions and favorable methanol pricing momentum, but the current technical setup is weak, and the share price is already close to near-term resistance. My direct view: hold off on buying now; it is better suited as a monitored hold than an immediate purchase at this pre-market level of 59.615.
Technically, MEOH is mixed to weak in the short term. The MACD histogram is -0.557 and still negatively expanding, which points to ongoing downside momentum. RSI_6 at 30.27 is near oversold, but not yet a strong reversal signal. Moving averages are converging, suggesting the stock is compressing rather than breaking out decisively. Price is trading below the pivot at 62.183 and near support at S1 60.075 / S2 58.772, so the pre-market level is not far from support but is still below the main pivot. Based on the current setup, this is not a strong momentum entry.
["Recent analyst target increases.", "Improving methanol pricing environment.", "Potential earnings lift in Q2 from higher commodity prices.", "Bullish options sentiment."]
["Negative MACD momentum.", "Valuation concerns from multiple firms.", "Institutional selling by M&G PLC.", "No strong proprietary buy signal."]
No usable quarterly financial snapshot was provided because the financial snapshot section returned an error. As a result, I cannot assess the latest quarter’s revenue, EBITDA, EPS, or margin growth directly. However, analyst commentary implies the upcoming quarter should benefit from stronger methanol prices and potentially much higher EBITDA versus Q1, which suggests improving operating momentum. Latest quarter season: not available from the provided data.
Analyst sentiment is constructive but not uniformly bullish. Recent price targets have been raised by Scotiabank, UBS, CIBC, JPMorgan, RBC, and BMO, reflecting better methanol pricing and earnings expectations. The bull case centers on upside from stronger commodity pricing and management’s capital allocation, while the bear case is mainly valuation after the stock’s rally and the possibility of normalization in methanol prices. Wall Street is split: pros see rising target prices and upside from pricing tailwinds; cons see the stock as fairly valued or vulnerable to commodity normalization.
